Nothing is easy to predict, especially not the development of organisms. However, predicting neuron cell growth has just become a little bit easier, thanks to CMU researchers.
Sep 11, 2023
0
1
One of the remaining mysteries of immunology is the exact mechanism that B cells use to generate millions of antibodies with different specificities to protect us from the plethora of pathogens in the environment.
Sep 7, 2023
0
73
A team of researchers at the University of Kentucky has found that a drug used to treat multiple sclerosis (MS) is potentially effective as a therapy for Alzheimer's disease.
Sep 1, 2023
1
37
Researchers at The University of Texas MD Anderson Cancer Center have uncovered a functional role for KRAS mutations in pancreatic cancer and rapidly translated these findings into a novel therapeutic approach combining a ...
Aug 24, 2023
0
33
Ask any neurologist: Parkinson's disease is a brain disorder. The conspicuous symptoms of Parkinson's disease—uncontrollable tremors, slowed down motions, and the feeling that one's feet are stuck to the ground—all stem ...
Aug 21, 2023
0
316
Northwestern Medicine scientists have developed a new cellular model of uterine fibroids that stem from common genetic mutations, which will accelerate further research and development of future treatments, according to findings ...
Aug 14, 2023
0
53
Mycobacterium tuberculosis (Mtb) is the pathogen that causes tuberculosis (TB), the world's deadliest infectious disease. Mtb is so successful and harmful because it can adapt to different conditions inside our bodies, allowing ...
Aug 8, 2023
0
25
The present variants of cancer immunotherapy such as immune checkpoint blockades only benefit a small subset of patients due to its immunosuppressive tumor microenvironment. The capacity to vaccinate tumors and reduce immunosuppression ...
Immune system T cells that should be able to kill cancer cells become dysfunctional or "exhausted" within hours of encountering a tumor, according to a study reported Aug. 3 in Nature Immunology.
Aug 3, 2023
0
69
New research reveals a type of monoclonal antibody already tested in certain forms of cancer may be a promising treatment in stopping the progression of amyotrophic lateral sclerosis, or ALS, a fatal neurodegenerative disease.
Jul 31, 2023
0
78
